Litcius/Paper detail

Apatinib combined with paclitaxel suppresses synergistically TNBC progression through enhancing ferroptosis susceptibility regulated SLC7A11/GPX4/ACSL4 axis

Xiaoxia Ma, Di Cao, Yan Zhang, Xiaoyun Ding, Zhiqiang Hu, Jing Wang

2025Cellular Signalling15 citationsDOI

Topics & Concepts

PaclitaxelCancer researchChemistryApatinibBiologyInternal medicineMedicineCancerFerroptosis and cancer prognosisRNA modifications and cancerMicroRNA in disease regulation
Apatinib combined with paclitaxel suppresses synergistically TNBC progression through enhancing ferroptosis susceptibility regulated SLC7A11/GPX4/ACSL4 axis | Litcius